Anti-DPYD monoclonal antibody

Pre-made anti-DPYD monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DPYD/DPYD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T75890-Ab-1/ GM-Tg-hg-T75890-Ab-2Anti-Human DPYD monoclonal antibodyHuman
GM-Tg-rg-T75890-Ab-1/ GM-Tg-rg-T75890-Ab-2Anti-Rat DPYD monoclonal antibodyRat
GM-Tg-mg-T75890-Ab-1/ GM-Tg-mg-T75890-Ab-2Anti-Mouse DPYD monoclonal antibodyMouse
GM-Tg-cynog-T75890-Ab-1/ GM-Tg-cynog-T75890-Ab-2Anti-Cynomolgus/ Rhesus macaque DPYD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T75890-Ab-1/ GM-Tg-felg-T75890-Ab-2Anti-Feline DPYD monoclonal antibodyFeline
GM-Tg-cang-T75890-Ab-1/ GM-Tg-cang-T75890-Ab-2Anti-Canine DPYD monoclonal antibodyCanine
GM-Tg-bovg-T75890-Ab-1/ GM-Tg-bovg-T75890-Ab-2Anti-Bovine DPYD monoclonal antibodyBovine
GM-Tg-equg-T75890-Ab-1/ GM-Tg-equg-T75890-Ab-2Anti-Equine DPYD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T75890-Ab-1/ GM-Tg-hg-T75890-Ab-2; GM-Tg-rg-T75890-Ab-1/ GM-Tg-rg-T75890-Ab-2;
GM-Tg-mg-T75890-Ab-1/ GM-Tg-mg-T75890-Ab-2; GM-Tg-cynog-T75890-Ab-1/ GM-Tg-cynog-T75890-Ab-2;
GM-Tg-felg-T75890-Ab-1/ GM-Tg-felg-T75890-Ab-2; GM-Tg-cang-T75890-Ab-1/ GM-Tg-cang-T75890-Ab-2;
GM-Tg-bovg-T75890-Ab-1/ GM-Tg-bovg-T75890-Ab-2; GM-Tg-equg-T75890-Ab-1/ GM-Tg-equg-T75890-Ab-2
Products NameAnti-DPYD monoclonal antibody
Formatmab
Target NameDPYD
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DPYD monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T75890-Ag-1Recombinant multi-species DPYD/ DHP/ DHPDHASE protein
    ORF Viral VectorvGMLP002087human DPYD Lentivirus particle
    ORF Viral VectorpGMLP002087human DPYD Lentivirus plasmid


    Target information

    Target IDGM-T75890
    Target NameDPYD
    Gene ID1806,99586,81656,715672,479935,101084380,281124,100057177
    Gene Symbol and SynonymsDHP,DHPDHASE,DPD,DPYD,DYPD,E330028L06Rik
    Uniprot AccessionQ12882,O89000,Q28007
    Uniprot Entry NameDPYD_HUMAN,DPYD_RAT,DPYD_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000188641
    Target ClassificationTumor-associated antigen (TAA)

    The target: DPYD, gene name: DPYD, also named as DHP, DHPDHASE, DPD. The protein encoded by this gene is a pyrimidine catabolic enzyme and the initial and rate-limiting factor in the pathway of uracil and thymidine catabolism. Mutations in this gene result in dihydropyrimidine dehydrogenase deficiency, an error in pyrimidine metabolism associated with thymine-uraciluria and an increased risk of toxicity in cancer patients receiving 5-fluorouracil chemotherapy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.